The effect of different vanadium compounds on proliferation and differentiation was examined in osteoblast-like UMR106 cells. Vanadate increased the cell growth in a biphasic manner, the higher doses inhibiting cell progression. Vanadyl stimulated cell proliferation in a dose-responsive manner. Similar to vanadate, pervanadate increased osteoblast-like cell proliferation in a biphasic manner but no inhibition of growth was observed. Vanadyl and pervanadate were stronger stimulators of cell growth than vanadate. Only vanadate was able to regulate the cell differentiation as measured by cell alkaline phosphatase activity. These results suggest that vanadium derivatives behave like growth factors on osteoblast-like cells and are potential pharmacological tools in the control of cell growth. (Mol Cell Biochem 145: 97-102, 1995) 
Introduction
Osteoblasts are important cells involved in bone formation. Their activity is regulated by several systemic hormones (growth hormone, GH; insulin; glucocorticoids; parathyroid hormone, PTH; vitamin D) and local factors like transforming growth factor (TGF), fibroblast growth factor (FGF), insulin-like growth factors (IGFs), platelet-derived growth factor (PDGF) [I-3] . Systemic hormones can act directly on the bone or by inducing the secretion ofcytokines and growth factors [4] . It has been found that human bone cells in culture produce a number of growth factors, many of which are known to be stored in human bone, including IGF-I, IGF-II, TGF-13 and PDGF [5] . The hormonal action is mediated by cell surface specific receptors identified in osteoblasts in culture [6] [7] [8] . On the other hand, several ions (Ca, Zn, P, Mn, Cu, V) also modulate the activity of the bone cells [9, 10] .
Vanadium is an essential nutritional element and its deficiency causes growth inhibition and skeletal deformation in animals [10] . Vanadate shows significant biological effects on bone development [11, 12] ; it also acts like an insulinmimetic factor [13] . Recently, different vanadium compounds, such as pervanadates, have been shown to stimulate the intracellular levels ofphosphoproteins [14] [15] [16] . Although the intimate molecular mechanism of their action is still unknown, it is probably mediated by the inhibition of protein phosphotyrosyl-phosphatases (PYPases) [14, 17] . We have recently shown that vanadate, vanadyl, peroxo-and hydroperoxovanadium compounds selectively inhibit a bone soluble alkaline phosphatase, partially characterized as a PTPase [18] .
The aim of the present study was to obtain a deeper insight into the effects of vanadium derivatives on the proliferation and differentiation of osteoblast-like UMR106 cells in culture. UMR106 cells are clonal osteosarcoma cells that have preserved many different properties ofosteoblasts, including cAMP responsiveness to PTH, high alkaline phosphatase and synthesis of bone-specific collagen [ 19] .
Materials and methods

Materials
Porcine insulin was obtained from Lilly Co, IGF-I from Bachem and bovine growth hormone from Wilhelmi. Vanadium (IV) oxide sulfate (vanadyl sulfate) was obtained from Merck, catalase and p-nitrophenylphosphate (pNPP) were obtained from SIGMA. Tissue culture materials were provided by Coming or Falcon. Dulbecco's modified Eagle's medium (DMEM), trypsin, ethylenediamine-tetraacetic acid (EDTA) were supplied by GIBCO and fetal bovine serum (FBS) by Gen (Argentina). All other chemicals were of analytical grade from SIGMA. Solutions of vanadate, vanadyl and peroxoderivates were prepared as previously reported [18] . In brief, pervanadate was obtained by reaction of orthovanadate with HzO 2 at 22~ for 15 min. The excess of H202 was removed with catalase.
Cell culture
Rat osteosarcoma cell line UMR106 was grown in DMEM supplemented with 10% FBS and antibiotics in a humidified atmosphere of 95% air/5% CO 2. Cells were grown at nearconfluence (70--80%) and they were subcultured using 0.1% trypsin-1 mM EDTA in Ca 2+-Mg2"-free phosphate-buffered saline (PBS). For experiments, about 2.5. 104 cells/ml were plated into 24 well/plates. After the culture reached 70% confluence, the cells were washed with DMEM without serum and incubated in 0.5 ml DMEM plus various concentrations of hormones or different vanadium compounds for 24 h.
Cell proliferation assay
A mitogenic bio.assay was carried out as described by Okajima et al. [:20] with some modifications. Briefly, cells in 24 well/plate were washed with PBS and fixed with 5% glutaraldehyde/PBS at room temperature for 10 min. Cells were then stained with 0.5% crystal violet/25% methanol for 10 rain. After that, the dye solution was discarded and the plate was washed with water and dried. The dye in the cells was extracted using 0.5 ml/well 0.1M glycine/HC1 buffer, pH 3.0/30% methanol and transfered to test tubes. Absorbance was read at 540 nm after a convenient sample dilution. In order to confirm that the colorimetric bioassay correlated with cell proliferation, the relationship between cell number/well and the absorbance at 540 nm of diluted extraction sample after crystal violet staining of a different set of wells was examined. Cell number was determined by trypsinization of 
Alkaline phosphatase activity
Cells were incubated at 37~ h in a serum-free medium containing different agents. The cell layer was washed with PBS and solubilized in 0.5 ml 0.1% Triton-X100. Aliquots of the total cell extract (10%) were used for protein determination using the Bio Rad Bradford technique [21] and 10-20% for measurement of alkaline phosphatase activity. The enzyme activity was assayed by the hydrolisis ofpNPP to pNP at 37~ for 15 min in 20 mM HEPES buffer pH 8.0 in the presence of 20 mM KCI and 30 mM MgC12. The absorbance at 405 nm was measured as previously described [18] . Alkaline phosphatase activity is known as a marker of mature osteoblast phenotype and this method has been extensively used to assess cell differentiation in cell culture systems [22] [23] [24] [25] .
Statistical methods
Data are expressed as the mean :t: SEM. Statistical differences were analyzed using Student's t-test or analysis of variance when suitable. Linear regression analysis was performed by the Pearson's correlation coefficient. Cells were exposed to DMEM plus different growth factors for 24 h. Cell proliferation was measured by the crystal violet bioassay and the cell differentiation as alkaline phosphatase activity. Results are expressed as % over basal (non addition), mean + SEM (n = 4). p values vs basal: *p < 0.01, #19 < 0.001.
Results
The addition of insulin, IGF-I and bovine GH to UMR106 cells in serum-free media produced a significant increase in cell proliferation after 24 h of incubation. The same hormonal doses inhibited cellular differentiation measured through alkaline phosphatase activity (Table 1) . Insulin and IGF-I seem to have a similar quantitative effect, while bGH showed a weak effect under comparative conditions. These results showed that the growth of osteoblast-like UM R 106 cells is regulated by different hormones and growth factors.
To determine if the UMR106 cells were also modulated by vanadium compounds acting as growth factors, we evaluated the effects of vanadate on cellular proliferation and differentiation. Vanadate stimulated cell proliferation in a biphasic curve manner, with a maximum obtained at 10-25 pM, but without further effects ( Fig. 2A) . High concentrations of vanadate induced a small decrease in cell proliferation. The action of vanadate upon cell differentiation is shown in a mirror curve with respect to the proliferative effect (Fig.  2B) . Maximal inhibition was observed at 5-25 laM and stimulation was seen at 75-100 pM. We have previously shown that vanadate, vanadyl and pervanadate (5-100 pM) directly inhibit the osteoblast-like cell alkaline phosphatase activity [ 18] . Accordingly, the results in Fig. 2B could be explained by a direct inhibition of vanadate on alkaline phosphatase. In order to test this hypothesis, in a new series of experiments, the assay was performed in the presence of 25 laM EDTA (Table 2 ). This reagent strongly complexes vanadate (Ka = 1015 , [26] ) which otherwise, could be free in the cell extract to inhibit alkaline phosphatase. In the presence of EDTA, the inhibitory effect of vanadate on cell differentiation was reproduced. These results suggest that the effect of vanadate on cell diferentiation, as assessed by alkaline phosphatase activity, was not a direct in vitro inhibitory effect ofvanadate but probably a change in the enzyme content.
Since some cellular types are able to reduce vanadate to vanadyl, which seems to be the effective mediator, we tested the effects of vanadyl cation on the UMR106 cells. Cells were incubated in DMEM plus different concentrations of vanadate at 37~ h. Alkaline phosphatase (ALP) in the cell extract was assayed in the absence or presence of 25 laM EDTA: basal activities were 273 + 14 and 306 + 32 nmol pNP/min.mg protein, respectively. Results are expressed as % over basal, mean + SEM (n = 6). p values vs their respective basal were: *p < 0.05; **p < 0.02; #p < 0.002; ##p < 0.001. Differences found between the assay in the presence and in the absence of EDTA, were not significant.
shows that vanadyl stimulated cell proliferation at all the used concentrations and did not inhibit cell growth under these conditions. On the other hand, vanadyl had no statistically significant effect upon cell differentiation as can be seen in the results of the alkaline phosphatase activity assay (Fig. 3B) .
Pervanadate has been proved to be a more potent insulinmimetic agent [17, 27] . Fig. 4A shows a dose-responsive effect of this vanadium derivative. Similar to vanadate action, pervanadate statistically increased cell proliferation at 5-25 laM. Higher concentrations did not affect the growth of the osteoblast-like cells. As in the case of vanadyl, pervanadate
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had no action on cell differentiation (Fig. 4B) as assayed by alkaline phosphatase activity. These results are in contrast with the direct effect of pervanadate previously observed in the fraction of UMR 106 cells [ 18] .
The effectiveness of the three vanadium derivatives at maximum dose was compared. Vanadyl (25 ~tM) and pervanadate (25 pM), which showed the maximum stimulation in cell proliferation, were 134 + 3 and 135 + 4% above basal, respectively, whereas vanadate (25 ~tM) increased osteoblast-like cell growth by 119 + 2% over basal (p < 0.001). These results show that vanadyl and pervanadate are stronger stimulators than vanadate.
Discussion
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The present study was undertaken to examine the effects of different vanadium compounds on osteoblast-like cell proliferation and differentiation in vitro. Vanadate increases cell growth in a biphasic manner. This pattern has been previously shown by Canalis in culture rat calvaria [1 !], Kato et al in rabbit costal chondrocyte culture [12] and Davidai et al in MC3T3-EI cells [16] . In all the cases, the higher concentrations tested clearly inhibited cell proliferation. Vanadyl and pervanadate seemed to be better mitogens since they did not inhibit cell growth in osteoblast-like UMRi06 cells and also showed a more potent effect than vanadate.
These vanadium compounds behave like growth factors: they stimulate cellular proliferation in a proportion similar to insulin and IGF-I ( Table 1) . The UMR106 cells possess binding sites for insulin and IGF-I, but at the doses used for insulin, the latter probably stimulates cell proliferation through Type-I IGF receptor (unpublished observations). These receptors became phosphorylated upon binding the cognate hormone [28] . Since vanadate has been postulated to specifically inhibit PTPases, it could regulate cell growth by enhancing insulin or IGF autophosphorylation. In adipose tissue it has been shown that vanadate stimulates glucose metabolism by a mechanism other than autophosphorylation of the insulin receptor [17] . Thus, vanadate could not produce additional activation of insulin effects in those cells. On the other hand, pervanadate was able to potentiate the hormone effect in adipocytes by increasing the autophosphorylation of insulin receptors [17] . We have previously shown [18] that UMRI06 cells have a cytosolic alkaline phosphatase, partially characterized as a PTPase. This enzyme was directly inhibited in the in vitro assay by vanadium derivatives. Thus, the inhibition of a specific PTPase is likely to play a role in the modulation of UMR106 cell growth. Pervanadate and vanadyl seem to be less important in the control of cell differentiation, as has been demonstrated by the ALP assay. It is known that pervanadate is unstable and spontaneously decomposes to vanadate [27] . Although we did not test this process during our cell incubation period, the absence ofpervanadate effect on cell differentiation (Fig. 4B) suggests that not enough vanadate was generated to inhibit cell differentiation (it has to be at least _> 2.5 ~tM, Fig. 213 ). On the other hand, we have previously shown [I 8 ] that both vanadyl and pervanadate directly inhibit a partially characterized citosolic PTPase in UMR 106 cells. Thus, this mechanism, although not directly tested by the authors, would partially explain the vanadium compound stimulatory effect on cell proliferation. Vanadate was the only compound which inhibited cell differentiation at mitogenic doses. This effect was not a direct in vitro inhibition of alkaline phosphatase activity but rather a decrease in the enzyme amount. Considering that the cell monolayer was resuspended in 0.5 ml solubilization solution, a rough estimate of vanadate concentration in the extract suggests that it should be diluted to the extent that it does not directly affect the alkaline phosphatase activity. The experiment performed in the presence of EDTA, in a concentration estimated to totally complex free vanadate [26] did not blunt out the vanadium effect on cell differentiation. A similar effect, induced by insulin, was observed in Ros 17/2.8 rat osteosarcoma cells [7] . However, Canalis et al. found that treatment with vanadate did not stimulate ALP activity in a calvaria culture [ 11 ] . This enzyme was inhibited in bone exposed to 1 mM vanadate, a dose which caused inhibition ofthymidine incorporation into DNA. In our study the higher doses of vanadate (> 75 laM) activated alkaline phosphatase, an effect not observed in the presence of other vanadium derivatives. This could be a compensatory effect of osteoblast-like cells, under a condition of decreased cell proliferation [22] . Those studies and the present one suggest that pervanadate as well as vanadyl can regulate cell proliferation without the cell growth inhibitory effect observed with vanadate. Whether these are tissue-specific effects of vana-dium derivatives or general effects on many cell types is currently under investigation in our laboratory.
In the last years, new derivatives ofvanadate having insulin-mimetic action have been searched for and they seem to be promisory as regards growth promoting effects. Thus, these compounds are potentially pharmacological tools in the control of metabolic states of insulin resistence and pathologies with bone growth alterations.
